Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06988761 · ClinicalTrials.gov registry record · NA
The Clinical Impact of Integrated Behavioral Health Techniques in Patients With Fibromyalgia
A NA study of Fibromyalgia, sponsored by Mayo Clinic.
- Active
- Registry status
- NA
- Development phase
- 300
- Enrollment target
- 1
- Study location
NCT06988761: Active NA study of Fibromyalgia, sponsored by Mayo Clinic.
NCT06988761 is a NA study of Fibromyalgia that is active but no longer recruiting, run by Mayo Clinic. The registered enrollment target is 300 participants, above the 175-participant average among 76 other Fibromyalgia trials with a reported enrollment target (71% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06988761, a NA study of Fibromyalgia, is active but no longer recruiting, sponsored by Mayo Clinic.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 300 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research is to assess the impact of using Lin Health to provide virtual long-term follow up care for patients with a diagnosis of fibromyalgia.
Primary Outcome
The Revised Fibromyalgia Impact Questionnaire (FIQR) is a self-report questionnaire designed to assess the impact of fibromyalgia on a patient's daily life. It evaluates function, overall impact, and symptoms experienced in the past 7 days. The FIQR uses an 11-point numeric scale (0 to 10) for each of the 21 questions, with higher scores indicating a greater impact of fibromyalgia.
Conditions Studied
Interventions
- BEHAVIORAL Standard of care treatment for Fibromyalgia
- BEHAVIORAL Longitudinal Behavioral Health Techniques
Study Locations (1)
Minnesota
- Mayo Clinic - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2025-06-09 |
| Est. Completion | 2026-06 |
| Phase | NA |
What the registry record for NCT06988761 still lists
NCT06988761 is an interventional study that assigns participants to a tested intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap, above the 175-participant average among 76 other Fibromyalgia trials with a reported enrollment target (71% higher).
The record links to 1 condition, with Fibromyalgia appearing as the primary indexed condition, and to 2 interventions - of which Standard of care treatment for Fibromyalgia is the first listed.
NCT06988761 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT06988761 about?
NCT06988761 is a clinical study titled "The Clinical Impact of Integrated Behavioral Health Techniques in Patients With Fibromyalgia". The purpose of this research is to assess the impact of using Lin Health to provide virtual long-term follow up care for patients with a diagnosis of fibromyalgia.
What is the current status of trial NCT06988761?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 300 participants. The study started on 2025-06-09. Estimated completion is 2026-06.
What conditions does trial NCT06988761 study?
This clinical trial studies the following conditions: Fibromyalgia.
What interventions are being tested in trial NCT06988761?
The interventions under investigation include: Standard of care treatment for Fibromyalgia (BEHAVIORAL), Longitudinal Behavioral Health Techniques (BEHAVIORAL).
Who is sponsoring clinical trial NCT06988761?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06988761 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Fibromyalgia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06988761's enrollment target sits among peer trials
300 13th of 76 higher than 62 of 76 other Fibromyalgia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Fibromyalgia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Auricular Neuromodulation in Veterans With Fibromyalgia
RECRUITING · NA
-
Effects of Breathing and Attention Training (BAT) on Pain Modulation
RECRUITING · NA
-
Neural Mechanisms of Light Driven Analgesia
RECRUITING · NA
-
Fibromyalgia Sleep A to ZZZ Study
RECRUITING · NA
-
Explosive Synchronization of Brain Network Activity in Chronic Pain
RECRUITING · NA
-
Brief Pain Exposure Therapy (BPET) For Nociplastic Pain
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00353483 · 300 participants
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
- NCT00588185 · 300 participants · NA
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
- NCT00682032 · 300 participants · NA
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
- NCT00870064 · 300 participants · NA
The Treatment of Type I Open Fractures in Pediatrics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI